Canada Life’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,600
| Closed | -$631K | – | 2322 |
|
|
2023
Q1 | $631K | Sell |
5,600
-3,800
| -40% | -$428K | ﹤0.01% | 1646 |
|
|
2022
Q4 | $1.08M | Buy |
9,400
+500
| +6% | +$57.5K | ﹤0.01% | 1491 |
|
|
2022
Q3 | $920K | Buy |
8,900
+1,100
| +14% | +$114K | ﹤0.01% | 1519 |
|
|
2022
Q2 | $780K | Hold |
7,800
| – | – | ﹤0.01% | 1560 |
|
|
2022
Q1 | $907K | Hold |
7,800
| – | – | ﹤0.01% | 1551 |
|
|
2021
Q4 | $880K | Buy |
+7,800
| New | +$880K | ﹤0.01% | 1566 |
|
|
2020
Q4 | – | Sell |
-2,500
| Closed | -$278K | – | 2666 |
|
|
2020
Q3 | $278K | Hold |
2,500
| – | – | ﹤0.01% | 1821 |
|
|
2020
Q2 | $261K | Buy |
+2,500
| New | +$261K | ﹤0.01% | 1843 |
|